How pharma distributes information to doctors is changing as rapidly as how doctors prefer to receive and process such information.
Via Pharma Guy, Lionel Reichardt / le Pharmageek, eMedToday
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
Your new post is loading...
Your new post is loading...
|
Pharma Guy's curator insight,
December 10, 2015 8:29 AM
You can learn more about programmatic digital ads by listening to this 5-minute Pharmaguy audio snippet: "Programmatic, Auction-Based Digital Ad Buying"; http://bit.ly/1REYhtk |
Does this include "off-label" information? If so, I understand now why most pharma presenters at the recent FDA off-label hearing focused more on communicating off-label info to payers than to HCPs.
P.S. MSLs and KOLs are important sources of info for docs and these sources are controlled by pharma; i.e., not independent sources of information.